CMSC | 0.04% | 25.13 | $ | |
CMSD | 0.16% | 25.05 | $ | |
GSK | -1.86% | 40.86 | $ | |
SCS | -3.26% | 12.89 | $ | |
RIO | -2.37% | 63.67 | $ | |
RBGPF | 5.79% | 60.5 | $ | |
NGG | 1.15% | 69.63 | $ | |
BTI | -0.39% | 37.425 | $ | |
AZN | -0.72% | 78.335 | $ | |
BCC | -1.93% | 141.95 | $ | |
BP | -0.14% | 32.715 | $ | |
RYCEF | 0% | 6.95 | $ | |
JRI | -0.53% | 13.329 | $ | |
BCE | -0.89% | 34.88 | $ | |
RELX | -0.32% | 47.975 | $ | |
VOD | -0.65% | 9.995 | $ |
South African Test cricketer suspended after positive drugs test
South African cricketer Zubayr Hamza has agreed to a voluntary suspension after testing positive for a prohibited substance, Cricket South Africa announced on Wednesday.
Hamza, 26, has played in six Test matches and one one-day international.
According to a CSA statement, Hamza tested positive for the substance Furosemide following an International Cricket Council anti-doping test on January 17.
Furosemide is a diuretic, prescribed to treat hypertension and reduce swelling caused by fluid build-up in the body. It is on the World Anti-Doping Agency’s banned list because of concerns that it may mask other drugs.
“Zubayr is not disputing the positive test, is cooperating fully with the ICC and has agreed to a voluntary suspension commencing immediately whilst written submissions are presented to the ICC,” said CSA.
“Furosemide is not a performance-enhancing substance and Zubayr has been able to identify how the substance entered his system.”
Hamza was named in the South African squad for a current one-day series against Bangladesh but withdrew before the series started for what CSA described at the time as “personal reasons”.
M.Kieffer--LiLuX